Aim: Diabetic patients with coronary artery disease have a high incidence of cardiovascular
events, which was associated with increased coronary plaque volume. Low-density …

Aim: Diabetic patients with coronary artery disease have a high incidence of cardiovascular
events, which was associated with increased coronary plaque volume. Low-density …

Aim: We have shown that aggressive lipid lowering by pitavastatin and atorvastatin results in
marked regression of atherosclerotic coronary lesions after acute coronary syndrome (ACS) …

Type 2 diabetes mellitus and impaired glucose tolerance (IGT) significantly induce
advanced coronary artery disease and systemic atherosclerosis. Thus, type 2 diabetes …

Aim: Coronary plaque regression is weak in acute coronary syndrome (ACS) patients with
diabetes mellitus (DM). We evaluated whether dual lipid-lowering therapy (DLLT) with …

Objectives Patients with type 2 diabetes mellitus (T2DM) are susceptible to coronary artery
disease (CAD), and coronary outcomes in these patients are heterogeneous. However, the …

Background To investigate the impact of diabetes on coronary artery total plaque volume
(TPV) and adverse events in long-term follow-up. Methods One-hundred-and-eight diabetic …

Background: The Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary
Syndrome (JAPAN-ACS) trial has found that early aggressive statin therapy in patients with …

Acute coronary syndrome (ACS) is associated with a high incidence of unstable plaques
beyond the culprit lesion, leading to early recurrence of cardiovascular events. Coronary …

Background High cardiovascular mortality has been reported in young patients with
diabetes. However, the underlying pathology in different age groups of patients with …